Am J Transplant, Volume 18, Suppl 3 Archives - Page 26 of 211 - ATC Abstracts

2018 American Transplant Congress
Assessing Fibrosis Burden in Renal Allograft with Chronic Damage Using Functional Magnetic Resonance Imaging
J. Wen,¹ W. Wang,² X. Ni,¹ Y. Yu,³ J. Chen,¹ L. Zhang,³ Z. Liu.¹
¹Jinling Hospital, Nanjing University School of Medicine, National Clinical Research Center of Kidney Diseases, Nanjing, Jiangsu, China; ²Nanjing Medical University, Jinling Clinical Hospital, Nanjing, Jiangsu, China; ³Department of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Background: Renal allograft fibrosis burden is a strong prognosticator for chronic damage and can only be accurately measured through transplant biopsy at present. We hypothesized…
2018 American Transplant Congress
Predicting Early and Late eGFR Variability in Kidney Transplant Recipients
K. Soliman, D. Taber, S. Zemin, V. Rao.
Department of Medicine and Department of Surgery, MUSC, Charleston, SC.
Introduction: eGFR variability is a known risk factor for graft loss. It is unclear what modifiable factors are significantly associated with this variability and if…
2018 American Transplant Congress
Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with AKIN Stage 2 and 3 Are Associated with Excellent Graft Outcomes
A. Kumar, K. Reddy, A. Srinivasan, J. Huskey, H. Khamash, M. Smith, A. Moss, R. Heilman.
Mayo Clinic, Phoenix.
BackgroundKTx from DD with AKI can be a good source of kidneys however these kidneys are underutilized. The aim of this study is to determine…
2018 American Transplant Congress
Peri-Operative Hemoglobin, Blood Transfusion and Delayed Graft Function in Kidney Transplant Recipients
S. MacIsaac, A. Ramankumar, C. Saw, V. Naessens, M. Cantarovich, D. Baran, S. Paraskevas, J. Tchervenkov, P. Chaudhury, S. Sandal.
MUHC, Montreal, Canada.
Background: Studies in the non-kidney transplant (KT) literature support an absolute hemoglobin concentration (Hb) threshold of 70 g/L for transfusion, unless otherwise indicated. Some reports…
2018 American Transplant Congress
Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient
P. Brown, D. Venkat.
Henry Ford Hospital, Detroit.
Objective: Limited real world data exists regarding the use of direct acting antivirals (DAA) for HCV viremia in renal transplant patients, particularly those with marked…
2018 American Transplant Congress
Oral Vancomycin Monotherapy versus Combination Therapy in Solid Organ Transplant Recipients with Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study
G. Korayem,^1,2,4 K. Eljaaly,^2,3 K. Matthias,^2,4 T. Zangeneh.^4,5
¹Department of Pharmaceutical Practices, Princess Nourah Bint Abdulrahman University, Riyadh, NA, Saudi Arabia; ²Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ; ³Department of Clinical Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ⁴Banner - University Medical Center Tucson, Tucson, AZ; ⁵Division of Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ.
Introduction:Solid organ transplant (SOT) recipients are at high risk of Clostridium difficile infection (CDI) and CDI recurrence. A combination of metronidazole and oral vancomycin is…
2018 American Transplant Congress
Early Sub-Clinical and Clinical TCMR Are Associated with Progressive Renal Allograft Dysfunction
A. Cherukuri, D. Chittka, R. Mehta, P. Sood, S. Hariharan.
UPMC, Pittsburgh.
Background: The clinical course and significance of early sub-clinical (SCR) and clinical TCMR (ACR) vs. no rejection (NR) is unclear. In this prospective study, we…
2018 American Transplant Congress
Liver Transplants from Older Donors Have Worse Outcomes in Elderly Recipients with Renal Dysfunction
R. Schilke,¹ M. Safwan,¹ S. Nagai,¹ M. Abouljoud,² A. Patel.¹
¹Transplant Institute, Henry Ford Health System, Detroit, MI; ²Nephrology, Henry Ford Health System, Detroit, MI.
Background: Most end stage liver disease patients suffer from concomitant renal insufficiency. We aimed to study influence of donor age on outcomes in elderly liver…
2018 American Transplant Congress
Assessment of Donor Specific Anti-HLA Antibodies throughout SLK Transplantation
P. Jindra, M. Kueht, S. Gray, D. Giang, M. Cusick, A. Rana, B. Murthy, W. Etheridge, J. Goss, R. Kerman.
Division of Abdominal Transplantation and Hepatobiliary Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.
Simultaneous Liver-Kidney transplantation provides a mechanism to protect the transplanted kidney from recognition by the recipient's immune response compared to solitary kidney transplant alone. High…
2018 American Transplant Congress
Pregnancy Outcomes after Living Liver Donation
G. Lee, E. Sonnenberg, K. Olthoff, D. Goldberg, P. Abt.
Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA; Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
Introduction: Women who have previously donated a kidney are at increased risk of pre-eclampsia. Nearly half of living liver donors are women of child-bearing age.…